Advanced Search:
Equity Index Forex Crypto Commodity

MEDP - Medpace Holdings

$392.57  1.5 (0.38%)

Updated: 17:12 May 5, 2024 EST

Next Hour's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Session's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Week's AI Forecast

N/A

Trend's Accuracy (AI)

N/A

Medpace Holdings's Position Within the Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

MEDPACE HOLDINGS - HISTORICAL DATA 6M

  • Last price

    $ 392.57

  • Daily change

    $ 1.5

  • Previous Close

    $ 391.07

  • Last Updated

    17:12 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.68 -0.2 0.38 0.3 0.26

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.06 1.89 1.69 1.43 1.51

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 35.58% 58.52% 76.72%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
0 -100% 391.7 -0.96% 395.51 18.63% 333.4

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
2.74 54.75 1.1 73.26

Medpace Holdings Technical Analysis News

Medpace Holdings

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.’s ISS Governance QualityScore as of March 1, 2024 is 7. The pillar scores are Audit: 4; Board: 10; Shareholder Rights: 8; Compensation: 5.

MEDPACE HOLDINGS'S HOLDERS RANK

List of holders with stock participation in Medpace Holdings.

Holder Rank Holder Shares Date Reported % Out Value